Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Hartmann

Showing results (481-490 of 626) with videos related to

Pageof 63
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 16, 2006
T-cell immunity to the folate receptor alpha is prevalent in women with breast or ovarian cancerKeith L Knutson, Christopher J Krco, Courtney L Erskine, et al.
Journal of Medicinal Chemistry|February 2, 1996
Structure-activity relationships of a new family of steroidal aromatase inhibitors. 1. Synthesis and evaluation of a series of analogs related to 19-[(methylthio)methyl]androstenedione (RU54115)D Lesuisse, J F Gourvest, O Benslimane, et al.
Breast Cancer Research and Treatment|September 2, 2011
Histologic findings in normal breast tissues: comparison to reduction mammaplasty and benign breast disease tissuesAmy C Degnim, Daniel W Visscher, Tanya L Hoskin, et al.
Gynecologic Oncology|March 26, 2013
Nutritional status, CT body composition measures and survival in ovarian cancerMichelle L Torres, Lynn C Hartmann, William A Cliby, et al.
Cancer Research|October 1, 1993
Comparison of loss of heterozygosity patterns in invasive low-grade and high-grade epithelial ovarian carcinomasM K Dodson, L C Hartmann, W A Cliby, et al.
Breast Cancer Research and Treatment|April 13, 2015
Ki-67 expression in sclerosing adenosis and adjacent normal breast terminal ductal lobular units: a nested case-control study from the Mayo Benign Breast Disease CohortAziza Nassar, Tanya L Hoskin, Melody L Stallings-Mann, et al.
Peerj|July 29, 2024
Escaping the benthos with Coral Reef Arks: effects on coral translocation and fish biomassJessica Carilli, Jason Baer, Jenna Marie Aquino, et al.
Plos One|July 21, 2009
Functional folate receptor alpha is elevated in the blood of ovarian cancer patientsEati Basal, Guiti Z Eghbali-Fatourechi, Kimberly R Kalli, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1994
Prognostic significance of p53 immunostaining in epithelial ovarian cancerL C Hartmann, K C Podratz, G L Keeney, et al.
Cancer Prevention Research (Philadelphia, Pa.)|February 1, 2014
Understanding the premalignant potential of atypical hyperplasia through its natural history: a longitudinal cohort studyLynn C Hartmann, Derek C Radisky, Marlene H Frost, et al.
Pageof 63

Showing results (481-490 of 626) with videos related to

Sort By:
Pageof 63
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 16, 2006
T-cell immunity to the folate receptor alpha is prevalent in women with breast or ovarian cancerKeith L Knutson, Christopher J Krco, Courtney L Erskine, et al.
Journal of Medicinal Chemistry|February 2, 1996
Structure-activity relationships of a new family of steroidal aromatase inhibitors. 1. Synthesis and evaluation of a series of analogs related to 19-[(methylthio)methyl]androstenedione (RU54115)D Lesuisse, J F Gourvest, O Benslimane, et al.
Breast Cancer Research and Treatment|September 2, 2011
Histologic findings in normal breast tissues: comparison to reduction mammaplasty and benign breast disease tissuesAmy C Degnim, Daniel W Visscher, Tanya L Hoskin, et al.
Gynecologic Oncology|March 26, 2013
Nutritional status, CT body composition measures and survival in ovarian cancerMichelle L Torres, Lynn C Hartmann, William A Cliby, et al.
Cancer Research|October 1, 1993
Comparison of loss of heterozygosity patterns in invasive low-grade and high-grade epithelial ovarian carcinomasM K Dodson, L C Hartmann, W A Cliby, et al.
Breast Cancer Research and Treatment|April 13, 2015
Ki-67 expression in sclerosing adenosis and adjacent normal breast terminal ductal lobular units: a nested case-control study from the Mayo Benign Breast Disease CohortAziza Nassar, Tanya L Hoskin, Melody L Stallings-Mann, et al.
Peerj|July 29, 2024
Escaping the benthos with Coral Reef Arks: effects on coral translocation and fish biomassJessica Carilli, Jason Baer, Jenna Marie Aquino, et al.
Plos One|July 21, 2009
Functional folate receptor alpha is elevated in the blood of ovarian cancer patientsEati Basal, Guiti Z Eghbali-Fatourechi, Kimberly R Kalli, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1994
Prognostic significance of p53 immunostaining in epithelial ovarian cancerL C Hartmann, K C Podratz, G L Keeney, et al.
Cancer Prevention Research (Philadelphia, Pa.)|February 1, 2014
Understanding the premalignant potential of atypical hyperplasia through its natural history: a longitudinal cohort studyLynn C Hartmann, Derek C Radisky, Marlene H Frost, et al.
Pageof 63